There is also the data of the body mass index (BMI), which revealed that reducing the BMI significantly affected the survival rates in both types of cancer, i.e., NSCLC and SCLC (Shepshelovich et al., 2019; Iyengar et al., 2016) leading ALI, which was a biomarker obtained from the calculation between the BMI (kg/m2) × albumin (g/dL)/neutrophil to-lymphocyte ratio (NLR) according to the theory (Jafri et al., 2013). This evidence concerns the gene ALB and non-small cell lung carcinoma.